Impact of conversion from pegylated interferon-α2b to interferon-α2a for treating recurrent hepatitis C after liver transplantation.
暂无分享,去创建一个
Y. Maehara | K. Shirabe | K. Kotoh | T. Ikegami | T. Yoshizumi | N. Furusyo | T. Fukuhara | Y. Soejima | Masaki Kato | S. Shimoda | T. Motomura